Research output per year
Research output per year
Fingerprint
Dive into the research topics where Marlies Mulder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Management of vancomycin-resistant Enterococcus faecium in Dutch health care institutes: a nation-wide survey
Mulder, M., Vendrik, K. E. W., van Kessel, S. A. M., Notermans, D. W., Schoffelen, A. F., Flipse, J., Hendrickx, A. P. A., van der Zwet, W. & Schneeberger-van der Linden, C., Jan 2025, In: Journal of Hospital Infection. 155, p. 51-59 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Adherence to and usefulness of the national treatment guideline for urinary tract infections (UTI) in a risk area
van Driel, A. A., Mulder, M., Stobberingh, E. E. & Verbon, A., 7 Sept 2022, In: BMC primary care. 23, 1, 224.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Antibodies against SARS-CoV-2 after natural infection in healthcare workers and clinical characteristics as putative antibody production prediction
Hanssen, D. A. T., Penders, J., Heijgele, K., de Leede, S., Mulder, M., Bank, L. E. A., Slaats, M. H. C., Savelkoul, P. H. M. & van Loo, I. H. M., 1 Aug 2022, In: Journal of Clinical Virology Plus. 2, 3, 5 p., 100089.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Migratory myiasis in a European traveller due to Hypoderma larvae
Verheijden, M., Laumen, L., Mulder, M., Boshoven, M., Roelfsema, J., Pronk, M., Visser, L. G. & Wegdam-Blans, M., 20 Aug 2022, In: Journal of Travel Medicine. 29, 5, 3 p., taac023.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
OXA-48-Producing Uropathogenic Escherichia coli Sequence Type 127, the Netherlands, 2015-2022
Mulder, M., Notermans, D. W., Wielders, C. C. H., Bos, J., Witteveen, S., Ganesh, V. A., Landman, F., de Haan, A., Linden, C.S.-V. D., Hendrickx, A. P. A. & Dutch CPE Surveillance Study Group, 1 Dec 2022, In: Emerging Infectious Diseases. 29, 12, p. 2563-2565 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open Access